Cantex Pharmaceuticals Announces Initiation of an Investigator-Initiated Phase 2 Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases

/PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...

Related Keywords

Miami ,Florida ,United States ,Daniel Kontoh Boateng ,Casey Mcdonald ,Juanf Rodriguez ,Rupesh Kotecha ,Stepheng Marcus ,Cantex Pharmaceuticals Inc ,Tv Therapeutics Inc ,Nasdaq ,Baptist Health South Florida ,Prnewswire Cantex Pharmaceuticals Inc ,Chief Executive Officer ,Central Nervous System Metastasis ,Miami Cancer Institute ,Baptist Health South ,Cantex Pharmaceuticals ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,